Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Post by gnote1on Jul 06, 2022 8:11pm
246 Views
Post# 34806938

Tough times all around!

Tough times all around!from FXstreet

Sundial was granted another extension by the NASDAQ to remain listed on the exchange. 
This extension is good through August 8th, which gives the company just over a month to get its stock price back over $1.00. The stock hasn’t closed over $1.00 per share since June of 2021. Sundial might need to have shareholders vote on a reverse split to remain listed. Reverse splits are often seen as a bearish sign that the company is struggling. Oddly enough, Sundial is sitting at a fairly strong financial position, and is actively looking for more acquisition targets. The company recently made a stalking horse bid for the assets of the now bankrupt Zenabis which is a subsidiary of Hexo (NASDAQ:HEXO).

and TSE:WEED. Canaccord reiterated its Sell rating for the stock and slashed its 12-month price target from $4.50 to $3.50.
<< Previous
Bullboard Posts
Next >>